D
Ionis Pharmaceuticals, Inc. IONS
$43.03 $0.050.12% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 26.67% -19.04% -23.92% 12.37% -18.35%
Total Depreciation and Amortization -3.66% -3.58% -2.26% -6.61% -4.21%
Total Amortization of Deferred Charges -0.93% 2.37% 5.69% 11.26% 18.60%
Total Other Non-Cash Items 23.19% 32.85% 24.68% 382.77% 345.32%
Change in Net Operating Assets -7.11% -202.53% -171.02% -11.47% -2.76%
Cash from Operations 33.36% -55.13% -62.90% 34.89% 24.12%
Capital Expenditure -393.28% -199.36% -90.21% 34.07% 62.54%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -184.50% -93.34% 53.37% -492.53% 198.39%
Cash from Investing -223.06% -121.15% 37.41% -1,025.70% 179.22%
Total Debt Issued -- -- -- -100.00% -100.00%
Total Debt Repaid 34.25% 90.85% 90.85% 99.97% 85.57%
Issuance of Common Stock 607.32% 611.24% 957.26% 6,140.30% 799.34%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -100.00% -93.31%
Cash from Financing 1,216.73% 160.12% -25.78% 1.91% -94.10%
Foreign Exchange rate Adjustments 1,585.37% -45.52% -177.56% -4.40% -87.23%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 102.53% -312.50% -228.01% -147.09% -34.67%